Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026 Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone by receiving Good Manufacturing Practices (GMP) certification from
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial RevolutionVenus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone in workforce development by
This key accreditation opens doors to expanded global business opportunities by enabling quicker approvals in other PIC/S member countries.Venus Remedies Limited, a leading exporter of affordable generic drugs with presence in more than 80 countries, has achieved a major regulatory milestone by receiving Good Manufacturing
Marketing approvals for bortezomib from Philippines and carboplatin from Morocco will enable the company to enhance its presence in ASEAN, African regionsVenus Remedies Ltd, a prominent oncology drug manufacturer, has secured marketing authorizations for two key cancer drugs, enhancing its global reach. The approvals
The UNICEF order for ceftriaxone supply is an endorsement of Venus Remedies’ exceptional quality standards and its position as a trusted partner in global healthcare supply chains The company also secures a mandate from the world's oldest international public health agency for supplying essential
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy Venus Remedies is among the largest Indian exporters of these drugs Ukraine is among the largest countries in Europe and its pharmaceutical market has been witnessing
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF This achievement is an endorsement of Venus Remedies' commitment to delivering top-quality pharmaceutical products worldwide Venus Remedies Limited, a leading global pharmaceutical company, has recently secured
The disbursement will bolster the company’s manufacturing capabilities and foster product diversification, including complex generics The grant emphasises the company’s commitment to driving innovation, entitles it to incentives for incremental sales of eligible pharmaceutical products Venus Remedies Ltd, one of India’s leading manufacturers of generic
Inputs by: Mr. Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd, and CEO, Venus Medicine Research Centre (VMRC)The upcoming Union Budget 2024-2025 will determine how well India progresses with regard to achieving its stated objectives of becoming the 'Pharmacy to the World' and embracing
This GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators The recognition demonstrates Venus Remedies’ persistence in adhering to stringent manufacturing standards and providing greater access to life-saving drugs in the African continent Venus Remedies, a
